Product
pA1c® a probiotic ingredient for glucose metabolic health
Top 10 Nutritional Supplements Trends in 2023. pA1c® for the nutritional management of blood glucose levels.
CoFounder & CEO
Genbioma Aplicaciones S.L.
Navarra, Navarra, Spain
Probiotics, Postbiotics & Microbial Metabolites for Metabolic Disorders Genbioma is a biotechnology company devoted to Microbiome Study for metabolic health.
Co-Founder, Investor and Managing Director at Genbioma Aplicaciones S.L.
Ph.D. in Food Sci and Tech, MSc Degree on Food Sci. & Tech and BSc Degree on Nutrition and Human Health. Awards: EIC Woman Leadership 2023. Probiota Pioneers 2022
Microbiome Study for the Food and Pharmacy sector. Personalized and precision Microbiome-based products (Probiotics & Postbiotics) for the nutritional management of metabolic disorders in Diabetes related conditions. Personal Profile. Focused on international market.
Member of EU Technical Committees on Food&Health, Co-author of 30 scientific articles, 6 international patents +50 R&D projects +50 Conferences. h-index: 12
My organisation
Skills
Interests
Product
pA1c® a probiotic ingredient for glucose metabolic health
Top 10 Nutritional Supplements Trends in 2023. pA1c® for the nutritional management of blood glucose levels.
Product
Probiotic food supplement for glucose control: Reglubetic(R)
Reglubetic® is a food supplement for glucose metabolic disorders (Diabetes). Affordable and industrially scaled up. Open to market.